Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1983 Oct 22;287(6400):1161–1164. doi: 10.1136/bmj.287.6400.1161

The lipoproteins: predictors, protectors, and pathogens.

B Lewis
PMCID: PMC1549404  PMID: 6414611

Full text

PDF
1161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. W., Nichols A. V., Pan S. S., Lindgren F. T. High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. Atherosclerosis. 1978 Feb;29(2):161–179. doi: 10.1016/0021-9150(78)90005-9. [DOI] [PubMed] [Google Scholar]
  2. Aviram M., Brook G. J. The effect of human plasma on platelet function in familial hypercholesterolemia. Thromb Res. 1982 Apr 15;26(2):101–109. doi: 10.1016/0049-3848(82)90019-6. [DOI] [PubMed] [Google Scholar]
  3. Barter P. J., Jones M. E. Kinetic studies of the transfer of esterified cholesterol between human plasma low and high density lipoproteins. J Lipid Res. 1980 Feb;21(2):238–249. [PubMed] [Google Scholar]
  4. Basu S. K., Brown M. S., Ho Y. K., Havel R. J., Goldstein J. L. Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7545–7549. doi: 10.1073/pnas.78.12.7545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beaumont J. L., Jacotot B., Buxtorf J. C., Silvestre M., Beaumont V. Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias. Artery. 1982;10(1):71–87. [PubMed] [Google Scholar]
  6. Bierman E. L., Albers J. J. Lipoprotein uptake by cultured human arterial smooth muscle cells. Biochim Biophys Acta. 1975 May 22;388(2):198–202. doi: 10.1016/0005-2760(75)90124-1. [DOI] [PubMed] [Google Scholar]
  7. Biesbroeck R., Oram J. F., Albers J. J., Bierman E. L. Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells. J Clin Invest. 1983 Mar;71(3):525–539. doi: 10.1172/JCI110797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brown M. S., Faust J. R., Goldstein J. L. Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts. J Clin Invest. 1975 Apr;55(4):783–793. doi: 10.1172/JCI107989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brown M. S., Goldstein J. L. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res. 1980 Jul;21(5):505–517. [PubMed] [Google Scholar]
  10. Brown M. S., Kovanen P. T., Goldstein J. L. Regulation of plasma cholesterol by lipoprotein receptors. Science. 1981 May 8;212(4495):628–635. doi: 10.1126/science.6261329. [DOI] [PubMed] [Google Scholar]
  11. Carlson L. A. Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia. Eur J Clin Invest. 1982 Feb;12(1):41–53. doi: 10.1111/j.1365-2362.1982.tb00938.x. [DOI] [PubMed] [Google Scholar]
  12. Christian J. C., Cheung S. W., Kang K., Harmath F. P., Huntzinger D. J., Powell R. C. Variance of plasma free and esterified cholesterol in adult twins. Am J Hum Genet. 1976 Mar;28(2):174–178. [PMC free article] [PubMed] [Google Scholar]
  13. Duffield R. G., Lewis B., Miller N. E., Jamieson C. W., Brunt J. N., Colchester A. C. Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial. Lancet. 1983 Sep 17;2(8351):639–642. doi: 10.1016/s0140-6736(83)92527-8. [DOI] [PubMed] [Google Scholar]
  14. Eisenberg S., Bilheimer D. W., Levy R. I., Lindgren F. T. On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. Biochim Biophys Acta. 1973 Dec 20;326(3):361–377. doi: 10.1016/0005-2760(73)90138-0. [DOI] [PubMed] [Google Scholar]
  15. Feinleib M., Garrison R. J., Fabsitz R., Christian J. C., Hrubec Z., Borhani N. O., Kannel W. B., Rosenman R., Schwartz J. T., Wagner J. O. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol. 1977 Oct;106(4):284–285. doi: 10.1093/oxfordjournals.aje.a112464. [DOI] [PubMed] [Google Scholar]
  16. Fielding P. E., Fielding C. J., Havel R. J., Kane J. P., Tun P. Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma. J Clin Invest. 1983 Mar;71(3):449–460. doi: 10.1172/JCI110789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fless G. M., Kirchhausen T., Fischer-Dzoga K., Wissler R. W., Scanu A. M. Serum low density lipoproteins with mitogenic effect on cultured aortic smooth muscle cells. Atherosclerosis. 1982 Feb;41(2-3):171–183. doi: 10.1016/0021-9150(82)90183-6. [DOI] [PubMed] [Google Scholar]
  18. Franceschini G., Sirtori C. R., Capurso A., 2nd, Weisgraber K. H., Mahley R. W. A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest. 1980 Nov;66(5):892–900. doi: 10.1172/JCI109956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. GOFMAN J. W., LINDGREN F. T., JONES H. B., LYON T. P., STRISOWER B. Lipoproteins and atherosclerosis. J Gerontol. 1951 Apr;6(2):105–119. doi: 10.1093/geronj/6.2.105. [DOI] [PubMed] [Google Scholar]
  20. Glueck C. J., Gartside P., Fallat R. W., Sielski J., Steiner P. M. Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia. J Lab Clin Med. 1976 Dec;88(6):941–957. [PubMed] [Google Scholar]
  21. Gofman J. W., Young W., Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation. 1966 Oct;34(4):679–697. doi: 10.1161/01.cir.34.4.679. [DOI] [PubMed] [Google Scholar]
  22. Goldberg A. P., Harter H. R., Patsch W., Schechtman K. B., Province M., Weerts C., Kuisk I., McCrate M. M., Schonfeld G. Racial differences in plasma high-density lipoproteins in patients receiving hemodialysis. A possible mechanism for accelerated atherosclerosis in white men. N Engl J Med. 1983 May 26;308(21):1245–1252. doi: 10.1056/NEJM198305263082101. [DOI] [PubMed] [Google Scholar]
  23. Goldbourt U., Medalie J. H. High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol. 1979 Mar;109(3):296–308. doi: 10.1093/oxfordjournals.aje.a112683. [DOI] [PubMed] [Google Scholar]
  24. Goldstein J. L., Brown M. S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974 Aug 25;249(16):5153–5162. [PubMed] [Google Scholar]
  25. Goldstein J. L., Hazzard W. R., Schrott H. G., Bierman E. L., Motulsky A. G. Genetics of hyperlipidemia in coronary heart disease. Trans Assoc Am Physicians. 1972;85:120–138. [PubMed] [Google Scholar]
  26. Gordon T., Kannel W. B., Castelli W. P., Dawber T. R. Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med. 1981 Aug;141(9):1128–1131. [PubMed] [Google Scholar]
  27. Gordon V., Innerarity T. L., Mahley R. W. Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro. J Biol Chem. 1983 May 25;258(10):6202–6212. [PubMed] [Google Scholar]
  28. Halloran L. G., Schwartz C. C., Vlahcevic Z. R., Nisman R. M., Swell L. Evidence for high-density lipoprotein-free cholesterol as the primary precursor for bile-acid synthesis in man. Surgery. 1978 Jul;84(1):1–7. [PubMed] [Google Scholar]
  29. Heiberg A. The heritability of serum lipoprotein and lipid concentrations. A twin study. Clin Genet. 1974;6(4):307–316. doi: 10.1111/j.1399-0004.1974.tb02091.x. [DOI] [PubMed] [Google Scholar]
  30. Henriksen T., Mahoney E. M., Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6499–6503. doi: 10.1073/pnas.78.10.6499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hjermann I., Velve Byre K., Holme I., Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet. 1981 Dec 12;2(8259):1303–1310. doi: 10.1016/s0140-6736(81)91338-6. [DOI] [PubMed] [Google Scholar]
  32. Hoff H. F., Gaubatz J. W. Isolation, purification, and characterization of a lipoprotein containing Apo B from the human aorta. Atherosclerosis. 1982 Apr;42(2-3):273–297. doi: 10.1016/0021-9150(82)90157-5. [DOI] [PubMed] [Google Scholar]
  33. Hui D. Y., Innerarity T. L., Mahley R. W. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors. J Biol Chem. 1981 Jun 10;256(11):5646–5655. [PubMed] [Google Scholar]
  34. Jansen H., van Tol A., Hülsmann W. C. On the metabolic function of heparin-releasable liver lipase. Biochem Biophys Res Commun. 1980 Jan 15;92(1):53–59. doi: 10.1016/0006-291x(80)91518-1. [DOI] [PubMed] [Google Scholar]
  35. Janus E. D., Nicoll A., Wootton R., Turner P. R., Magill P. J., Lewis B. Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia. Eur J Clin Invest. 1980 Apr;10(2 Pt 1):149–159. doi: 10.1111/j.1365-2362.1980.tb02075.x. [DOI] [PubMed] [Google Scholar]
  36. Kannel W. B., Castelli W. P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med. 1979 Jan;90(1):85–91. doi: 10.7326/0003-4819-90-1-85. [DOI] [PubMed] [Google Scholar]
  37. Knight B. L., Patel D. D., Soutar A. K. The regulation of 3-hydroxy-3-methylglutaryl-CoA reductase activity, cholesterol esterification and the expression of low-density lipoprotein receptors in cultured monocyte-derived macrophages. Biochem J. 1983 Feb 15;210(2):523–532. doi: 10.1042/bj2100523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Knuiman J. T., Hermus R. J., Hautvast J. G. Serum total and high density lipoprotein (HDL) cholesterol concentrations in rural and urban boys from 16 countries. Atherosclerosis. 1980 Aug;36(4):529–537. doi: 10.1016/0021-9150(80)90245-2. [DOI] [PubMed] [Google Scholar]
  39. Knuiman J. T., West C. E. HDL cholesterol in men from thirteen countries. Lancet. 1981 Aug 15;2(8242):367–368. doi: 10.1016/s0140-6736(81)90687-5. [DOI] [PubMed] [Google Scholar]
  40. Krauss R. M., Burke D. J. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982 Jan;23(1):97–104. [PubMed] [Google Scholar]
  41. Krauss R. M. Regulation of high density lipoprotein levels. Med Clin North Am. 1982 Mar;66(2):403–430. doi: 10.1016/s0025-7125(16)31427-4. [DOI] [PubMed] [Google Scholar]
  42. Lewis B., Chait A., Sigurdsson G. Serum lipoprotiens in four European communities: a quantitative comparison. Eur J Clin Invest. 1978 Jun;8(3):165–173. doi: 10.1111/j.1365-2362.1978.tb00830.x. [DOI] [PubMed] [Google Scholar]
  43. Mahley R. W. Apolipoprotein E and cholesterol metabolism. Klin Wochenschr. 1983 Mar 1;61(5):225–232. doi: 10.1007/BF01496128. [DOI] [PubMed] [Google Scholar]
  44. Mahley R. W. Atherogenic hyperlipoproteinemia. The cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. Med Clin North Am. 1982 Mar;66(2):375–402. doi: 10.1016/s0025-7125(16)31426-2. [DOI] [PubMed] [Google Scholar]
  45. Micheli H., Pometta D., Jornot C., Scherrer J. R. High density lipoprotein cholesterol in male relatives of patients with coronary heart disease. Atherosclerosis. 1979 Mar;32(3):269–276. doi: 10.1016/0021-9150(79)90170-9. [DOI] [PubMed] [Google Scholar]
  46. Miller G. J., Miller N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975 Jan 4;1(7897):16–19. doi: 10.1016/s0140-6736(75)92376-4. [DOI] [PubMed] [Google Scholar]
  47. Miller N. E., Hammett F., Saltissi S., Rao S., van Zeller H., Coltart J., Lewis B. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) 1981 May 30;282(6278):1741–1744. doi: 10.1136/bmj.282.6278.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Miller N. E., Thelle D. S., Forde O. H., Mjos O. D. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977 May 7;1(8019):965–968. doi: 10.1016/s0140-6736(77)92274-7. [DOI] [PubMed] [Google Scholar]
  49. Miller N. E., Weinstein D. B., Carew T. E., Koschinsky T., Steinberg D. Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts. J Clin Invest. 1977 Jul;60(1):78–88. doi: 10.1172/JCI108772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Nicoll A., Miller N. E., Lewis B. High-density lipoprotein metabolism. Adv Lipid Res. 1980;17:53–106. doi: 10.1016/b978-0-12-024917-6.50008-2. [DOI] [PubMed] [Google Scholar]
  51. Niehaus C. E., Nicoll A., Wootton R., Williams B., Lewis J., Coltart D. J., Lewis B. Influence of lipid concentrations and age on transfer of plasma lipoprotein into human arterial intima. Lancet. 1977 Sep 3;2(8036):469–471. doi: 10.1016/s0140-6736(77)91600-2. [DOI] [PubMed] [Google Scholar]
  52. Nupuf M. S., Sutherland W. H. High density lipoprotein levels in children of young men with ischaemic heart disease. Atherosclerosis. 1979 Jul;33(3):365–370. doi: 10.1016/0021-9150(79)90188-6. [DOI] [PubMed] [Google Scholar]
  53. Oram J. F., Albers J. J., Cheung M. C., Bierman E. L. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J Biol Chem. 1981 Aug 25;256(16):8348–8356. [PubMed] [Google Scholar]
  54. Quarfordt S., Hanks J., Jones R. S., Shelburne F. The uptake of high density lipoprotein cholesteryl ester in the perfused rat liver. J Biol Chem. 1980 Apr 10;255(7):2934–2937. [PubMed] [Google Scholar]
  55. Reid D. D., Hamilton P. J., McCartney P., Rose G., Jarrett R. J., Keen H. Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet. 1976 Nov 6;2(7993):979–984. doi: 10.1016/s0140-6736(76)90830-8. [DOI] [PubMed] [Google Scholar]
  56. Robertson F. W., Cumming A. M. Genetic and environmental variation in serum lipoproteins in relation to coronary heart disease. J Med Genet. 1979 Apr;16(2):85–100. doi: 10.1136/jmg.16.2.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Ross R., Harker L. Hyperlipidemia and atherosclerosis. Science. 1976 Sep 17;193(4258):1094–1100. doi: 10.1126/science.822515. [DOI] [PubMed] [Google Scholar]
  58. Rudel L. L., Shah R., Greene D. G. Study of the atherogenic dyslipoproteinemia induced by dietary cholesterol in rhesus monekys (Macaca mulatta). J Lipid Res. 1979 Jan;20(1):55–65. [PubMed] [Google Scholar]
  59. Schaefer E. J., Heaton W. H., Wetzel M. G., Brewer H. B., Jr Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis. 1982 Jan-Feb;2(1):16–26. doi: 10.1161/01.atv.2.1.16. [DOI] [PubMed] [Google Scholar]
  60. Schaefer E. J., Zech L. A., Schwartz D. E., Brewer H. B., Jr Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann Intern Med. 1980 Aug;93(2):261–266. doi: 10.7326/0003-4819-93-2-261. [DOI] [PubMed] [Google Scholar]
  61. Schmitz G., Assmann G. Isolation of human serum HDL1 by zonal ultracentrifugation. J Lipid Res. 1982 Aug;23(6):903–910. [PubMed] [Google Scholar]
  62. Schonfeld G., Weidman S. W., Witztum J. L., Bowen R. M. Alterations in levels and interrelations of plasma apolipoproteins induced by diet. Metabolism. 1976 Mar;25(3):261–275. doi: 10.1016/0026-0495(76)90084-6. [DOI] [PubMed] [Google Scholar]
  63. Segal P., Rifkind B. M., Schull W. J. Genetic factors in lipoprotein variation. Epidemiol Rev. 1982;4:137–160. doi: 10.1093/oxfordjournals.epirev.a036244. [DOI] [PubMed] [Google Scholar]
  64. Semmens J., Rouse I., Beilin L. J., Masarei J. R. Relationship of plasma HDL-cholesterol to testosterone, estradiol, and sex-hormone-binding globulin levels in men and women. Metabolism. 1983 May;32(5):428–432. doi: 10.1016/0026-0495(83)90002-1. [DOI] [PubMed] [Google Scholar]
  65. Shattil S. J., Anaya-Galindo R., Bennett J., Colman R. W., Cooper R. A. Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest. 1975 Mar;55(3):636–643. doi: 10.1172/JCI107971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Sigurdsson G., Nicoll A., Lewis B. Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects. J Clin Invest. 1975 Dec;56(6):1481–1490. doi: 10.1172/JCI108229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Solberg L. A., Strong J. P. Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis. 1983 May-Jun;3(3):187–198. doi: 10.1161/01.atv.3.3.187. [DOI] [PubMed] [Google Scholar]
  68. St Clair R. W., Greenspan P., Leight M. Enhanced cholesterol delivery to cells in culture by low density lipoproteins from hypercholesterolemic monkeys. Arteriosclerosis. 1983 Jan-Feb;3(1):77–86. doi: 10.1161/01.atv.3.1.77. [DOI] [PubMed] [Google Scholar]
  69. Stone N. J., Levy R. I., Fredrickson D. S., Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation. 1974 Mar;49(3):476–488. doi: 10.1161/01.cir.49.3.476. [DOI] [PubMed] [Google Scholar]
  70. Tatami R., Mabuchi H., Ueda K., Ueda R., Haba T., Kametani T., Ito S., Koizumi J., Ohta M., Miyamoto S. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation. 1981 Dec;64(6):1174–1184. doi: 10.1161/01.cir.64.6.1174. [DOI] [PubMed] [Google Scholar]
  71. Tolleshaug H., Goldstein J. L., Schneider W. J., Brown M. S. Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia. Cell. 1982 Oct;30(3):715–724. doi: 10.1016/0092-8674(82)90276-8. [DOI] [PubMed] [Google Scholar]
  72. Turley S. D., Andersen J. M., Dietschy J. M. Rates of sterol synthesis and uptake in the major organs of the rat in vivo. J Lipid Res. 1981 May;22(4):551–569. [PubMed] [Google Scholar]
  73. Turner P. R., Miller N. E., Cortese C., Hazzard W., Coltart J., Lewis B. Splanchnic metabolism of plasma apolipoprotein B: studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects. J Clin Invest. 1981 Jun;67(6):1678–1686. doi: 10.1172/JCI110205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Tyroler H. A., Heiss G., Schonfeld G., Cooper G., Heyden S., Hames C. G. Apolipoprotein A-I, A-II and C-II in black and white residents of Evans County. Circulation. 1980 Aug;62(2):249–254. doi: 10.1161/01.cir.62.2.249. [DOI] [PubMed] [Google Scholar]
  75. Wiklund O., Wilhelmsen L., Elmfeldt D., Wedel H., Valek J., Gustafson A. Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. Atherosclerosis. 1980 Sep;37(1):47–53. doi: 10.1016/0021-9150(80)90092-1. [DOI] [PubMed] [Google Scholar]
  76. Yamamoto A., Matsuzawa Y., Kishino B., Hayashi R., Hirobe K., Kikkawa T. Effects of probucol on homozygous cases of familial hypercholesterolemia. Atherosclerosis. 1983 Aug;48(2):157–166. doi: 10.1016/0021-9150(83)90102-8. [DOI] [PubMed] [Google Scholar]
  77. Zilversmit D. B. Cholesterol flux in the atherosclerotic plaque. Ann N Y Acad Sci. 1968 Nov 21;149(2):710–724. doi: 10.1111/j.1749-6632.1968.tb53830.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES